Clinical trials
Cardiovascular Events clinical trials
Below are recruiting cardiovascular events clinical trials, each written for real people, not researchers. We’re tracking 71 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06295679Recruiting
Repatha plus standard care for heart disease in Chinese patients
This study tests whether adding Repatha (a weekly injection that lowers cholesterol) to your usual heart medications can reduce the risk of future heart attacks, strokes, or other heart problems. It is for people who have already had a heart attack or stroke, or have certain high-risk conditions.
Beijing, Beijing MunicipalityAges 18–150 - NCT07136012RecruitingPhase 3
Olpasiran trial to lower Lp(a) and prevent first heart attack or stroke
This trial tests if olpasiran can lower a type of cholesterol called Lp(a) to help prevent a first major heart attack, stroke, or other heart problems. It is for people at higher risk due to risk factors or early signs of artery disease, but who have not yet had a heart attack or stroke.
Alexander City, AlabamaAges 50–105 - NCT06318767Recruiting
Foot Blood Flow Measurements to Predict Limb and Heart Events
This study measures how blood flows through your foot using ultrasound to see if it can predict serious problems with your leg or heart in people with severe circulation problems. The goal is to find a simple test that helps doctors decide the best treatment for you.
AmiensAges 18 years+ - NCT05922202Recruiting
Studying how frailty affects outcomes in COPD
This study looks at whether frailty (how weak or vulnerable someone is) changes the risk of heart-related events and death in people with COPD. It may help doctors better predict who is at higher risk and tailor care.
ModenaAges 40 years+ - NCT06473272Recruiting
Ultrasound to study neck artery plaques and predict risk
This study uses different ultrasound techniques to look at plaques in the neck artery and predict future heart or stroke events. It may help doctors understand which plaques are more dangerous.
Shanghai, Shanghai MunicipalityAges 40–100 - NCT07052799RecruitingPhase 3
Should you pause aspirin before a colonoscopy?
This trial compares stopping aspirin versus continuing it before a colonoscopy in people who take aspirin to prevent heart problems. The goal is to find out which approach is safer and works best.
Hong KongAges 18 years+ - NCT05799898Recruiting
Fast heart and vessel check for people on immune cancer drugs
This trial looks at a faster heart and blood-vessel assessment for people who are taking immune cancer drugs and have been referred because they might be having a heart-related side effect. It may help by speeding up evaluation and treatment decisions when symptoms raise concern.
ParisAges 18 years+ - NCT05943821RecruitingPhase 3
Allopurinol to lower heart and stroke risks in high-risk people
This trial studies whether allopurinol can reduce the chance of cardiovascular events like heart attack, stroke, or related problems in people who are at higher risk. It targets people with higher uric acid and other risk factors, to see if lowering uric acid helps protect the heart.
Poznan, WielkopolskaAges 40–70 - NCT04809506Recruiting
Blood and genetic tests to predict future heart problems
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
ToulouseAges 18–99 - NCT06087848RecruitingPhase 1/Phase 2
StromaForte stem cell therapy for heart event prevention
This trial tests a stem cell product called StromaForte to see if it can reduce cardiovascular events like heart attacks in people with stable medical conditions. It may help if you have heart or blood vessel issues that have been stable for at least six months.
Nassau, The BahamasAges 25–85 - NCT06951867Recruiting
Tezspire heart safety study
This study looks at whether the asthma medicine Tezspire (tezepelumab) affects the risk of heart problems compared to other standard treatments for severe asthma. It will help doctors understand if Tezspire is safe for your heart.
Wilmington, DelawareAges 12–130 - NCT07485283RecruitingPhase 4
Shingles vaccine for preventing heart problems and dementia
This trial tests whether a shingles vaccine can help prevent heart attacks, strokes, and dementia in older adults. If you are 65 or older and haven't had the shingles vaccine before, you may be able to join.
HellerupAges 65 years+ - NCT06652776Enrolling by invitation
Italian COPD patient registry study
This study is creating a registry to better understand Chronic Obstructive Pulmonary Disease (COPD) in Italian patients. It will collect information from people with COPD to improve care and research.
Milan, MilanAges 40 years+ - NCT05531474Recruiting
Bariatric surgery to lower future heart and stroke events
This trial looks at whether weight-loss surgery can reduce the chances of heart attack, stroke, or other serious heart problems in people at higher heart risk. You might be offered surgery and followed over time to see if cardiovascular events are reduced.
Hamilton, OntarioAges 18 years+ - NCT06919302Recruiting
Digital heart health app for heart disease patients
This study tests a digital heart health app combined with lifestyle coaching to help people with heart disease or diabetes manage their cholesterol and overall heart health. It aims to see if the app can improve outcomes for people already taking a statin.
Toronto, OntarioAges 45 years+ - NCT06519292Recruiting
Heart side effects from immunotherapy in cancer patients
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
Amsterdam, North HollandAges 50 years+ - NCT07539532Recruiting
AI model to predict heart problems after stomach surgery
This study compares a new artificial intelligence tool with traditional methods to predict which patients might have heart-related complications after gastrointestinal surgery. The goal is to find better ways to identify high-risk patients and potentially improve their care.
Hà NộiAges 16 years+ - NCT07000357RecruitingPhase 3
Study of AZD0780 to reduce heart attack and stroke risk
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
Athens, AlabamaAges 18 years+ - NCT07157774RecruitingPhase 3
Muvalaplin for heart disease in people with high lipoprotein(a)
This study tests a new medicine called muvalaplin that lowers a specific type of cholesterol linked to heart disease. It aims to see if muvalaplin can reduce the risk of future heart attacks, strokes, or related procedures in people with high levels of this cholesterol.
Birmingham, AlabamaAges 18 years+ - NCT07293260RecruitingPhase 3
Olpasiran heart scan study for high Lp(a) patients
This study tests if a medication called olpasiran can lower a type of fat in your blood called Lp(a), which is linked to heart problems. You take the medicine or a placebo and get a special heart scan to see changes in your arteries.
Bridgeport, ConnecticutAges 35–80 - NCT04183426Recruiting
Check heart risk tests before planned AAA repair
This study uses a hand/eye pressure test (tonometry) and an ultrasound scan (duplex ultrasound) to see if they can predict future heart or blood vessel events in people with an abdominal aortic aneurysm (AAA) who are planning elective surgery. It may help doctors choose the safest follow-up and treatments for you after repair.
Nijmegen, GelderlandAges 18 years+ - NCT06567795Recruiting
Monitoring heart risk with a wearable sensor in diabetes
This trial tests a wearable chest sensor (called HEMOTAG) to monitor heart events in people with long-standing Type 2 diabetes who also have heart disease or specific diabetes-related complications. The sensor is worn at home for short periods to catch early signs of heart trouble, aiming to improve personalized care.
West Palm Beach, FloridaAges 40 years+ - NCT07168421RecruitingPhase 4
Landiolol to prevent fast heart rate during major surgery
This trial tests a short-acting medicine called landiolol to see if it can prevent dangerously fast heart rates during and after major surgery. It is for people who have heart risks and are having a planned non-cardiac surgery.
BernAges 45 years+ - NCT07349498Recruiting
Heart health after stem cell transplant
This study follows patients who have had a stem cell transplant to see how their heart and blood vessels are doing over time. It helps doctors learn about long-term heart risks after transplant.
Beijing, Beijing MunicipalityAges Any age
Hear when a new Cardiovascular Events trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular events?
- Yes. Clin2 currently lists 71 recruiting cardiovascular events studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular events trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular events trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.